ESMO 2023: PSMAfore Phase 3 Trial of ... - Advanced Prostate...

Advanced Prostate Cancer

21,056 members26,262 posts

ESMO 2023: PSMAfore Phase 3 Trial of [177Lu]Lu-PSMA-617 in Taxane-Naive Patients with Metastatic Castration Resistant Prostate Cancer

swwags profile image
3 Replies

Apologies if this was already posted:

urotoday.com/conference-hig...

Written by
swwags profile image
swwags
To view profiles and participate in discussions please or .
Read more about...
3 Replies
j-o-h-n profile image
j-o-h-n

If indeed apologies are required.......... Then, I apologize.......

But keep posting cause we need the information that you bring to the table.

Good Bless and keep up the good work....

Good Luck, Good Health and Good Humor.

j-o-h-n Friday 10/27/2023 2:07 PM DST

swwags profile image
swwags in reply to j-o-h-n

The graphics alone help explain the outcomes and dumbed this article down for me.

j-o-h-n profile image
j-o-h-n in reply to swwags

Jeezamacripe........They tore out a page from my coloring book.....and they colored it too!!!!!!!🤔 Dirty rassafrats.....

Good Luck, Good Health and Good Humor.

j-o-h-n Friday 10/27/2023 3:00 PM DST

You may also like...

225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer

tandem theraphy is available somewhere in Europe? https://pubmed.ncbi.nlm.nih.gov/31758224/...

Lu-177-PSMA-I&T for low volume Metastatic Castration-Resistant Prostate Cancer

Germany recently. Is anyone familiar with Lu-177-PSMA-I&T for Metastatic Castration-Resistant...

promising against soft tissue and bone metastasis: AMG 509

https://www.urotoday.com/conference-highlights/esmo-2023/esmo-2023-prostate-cancer/147455-esmo-20

FDA Grants Fast Track Designation for 177Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer

the LU177 now available?...

Adaptive dosing: very promising results with Enzalutamide + Lutetium

https://www.urotoday.com/video-lectures/esmo-2023/video/3699-enza-p-trial-shows-promise-for-enzaluta